Theolytics is a biotechnology company harnessing viruses to combat cancer.

A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population.

In addition to advancing an internal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.

Address:
Sherard Building,
Edmund Halley Road,
Oxford Science Park,
Littlemore,
Oxford
OX4 4DQ

Website: Theolytics